Enantioselective gas chromatography-negative ion chemical ionization mass spectrometry for methylphenidate in human plasma

Journal of Analytical Toxicology

Volumn 23, Issue 6, 1999, Pages 524-530

  Lin, Shen Nan ^a   Andrenyak, David M ^a   Moody, David E ^a   Foltz, Rodger L ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; ACETIC ACID ETHYL ESTER; HEXANE; HYDROCHLORIC ACID; METHYLPHENIDATE;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; ENANTIOMER; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; RACEMIC MIXTURE; STEREOCHEMISTRY;

EID: 0032845145     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/23.6.524     Document Type: Article

References (30)

1. N.J. Giarman. Antidepressant drugs. In Drill's Pharmacology in Medicine, 3rd ed, J.R. DiPalma, Ed. McGraw-Hill, New York, NY, 1965, p 368.
2. R. Barkley. A review of stimulant drugs. Research with hyperactive children. J. Child Psychol. Psychiatry Allied Discip. 18: 137-165 (1977).
3. T.S. Spencer, T. Wilens, J. Biederman, S.V. Faraone, S. Ablon, and K.A. Lapey. A double blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 52: 434-443 (1995).
4. L.L. Greenhill and B.B. Osman. Ritalin: Theory and Patient Management. Liebert, New York, NY, 1991.
5. D. Bruera, C. Renneis, A.H.G. Paterson, and R.N. MacDonald. Narcotics plus methylphenidate (ritalin) for advanced cancer pain. Am. J. Nurs. 11: 1555-1556 (1988).
6. R.G. Klein. The role of methylphenidate in psychiatry. Arch. Gen. Psychiatry 52: 429-433 (1995).
7. F.R. Levin, S.M. Evans, D.M. McDowell, and H.D. Kleber. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J. Clin. Psychiatry 59: 300-305 (1998).
8. J. Grabowski, J.D. Roache, J.M. Schmitz, H. Rhoades, D. Creson, and A. Korszun. Replacement medication for cocaine dependence: methylphenidate. J. Clin. Psychopharmacol. 17: 485-488 (1997).
9. E.J. Khantzian, F.H. Gawin, C. Riordan, and H.D. Kleber. Methylphenidate treatment of cocaine dependence: a preliminarty report. J. Subst. Abuse Treat. 1: 107-112 (1984).
10. E.J. Khantzian. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. Am. J. Psychiatry 140: 784-785 (1983).
11. F.H. Gawin, C. Riordan, and H.D. Kleber. Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am. J. Drug Alcohol Abuse 11: 193-197 (1985).
12. N.D. Volkow, Y.-S. Ding, J.S. Fowler, G.-J. Wang, J. Logan, J.S. Gatley, S. Dewey, C. Ashby, J. Liebermann, R. Hitzemann, and A.P. Wolf. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry 52: 456-463 (1995).
13. 14C studies in man and animals. J. Pharmacol. Exp. Ther. 191: 535-547 (1974).
14. S.J. Soldin, J.M. Chan, B.M. Hill, and J.M. Swanson. A liquid chromatographic analysis for methylphenidate (Ritalin) in serum. Clin. Chem. 25: 401-404 (1979).
15. M. Lalande, D.L. Wilson, and I.J. VcGilveray. HPLC determination of methylphenidate in human plasma. J. Liq. Chromatogr. 10: 2257-2264 (1987).
16. R. Huffman, J.W. Blake, R. Ray, J. Noonan, and P.W. Murdick. Methylphenidate blood plasma levels in the horse determined by derivative gas-liquid chromatography-electron capture. J. Chrovmatogr. Sci. 12: 382-384 (1974).
17. B.D. Potts, C.A. Martin, and M. Vore. Gas-chromatographic quantification of methylphenidate in plasma with use of solid-phase extraction and nitrogen-sensitive detection. Clin. Chem. 30: 1374-1377 (1984).
18. C.T. Gualtieri, R.E. Hicks, K. Patrick, S.R. Schroeder, and G.R. Breese. Clinical correlates of methylphenidate blood levels. Ther. Drug Monit. 6: 379-392 (1984).
19. H.K. Lim, J.W. Hubbard, and K.K. Midha. Development of enantioselective gas chromatographic assay for dl-threomethylphenidate in biological fluids. J. Chromatogr. 378: 109-123 (1986).
20. N.R. Srinivas, D. Quinn, J.W. Hubbard, and K.K. Midha. Stereoselective disposition of methylphenidate in children with attention-deficit disorder. J. Pharmacol. Exp. Ther. 241: 300-306 (1987).
21. K. Nakajima, H. Kotaki, Y. Saitoh, and F. Nakagawa. Determination of methylphenidate and its metabolite in plasma by gas chromatography-chemical ionization mass spectrometry. Chem. Pharm. Bull. 34: 1701-1708 (1986).
22. K. Patrick. Capillary gas chromatographic-mass spectrometric analysis of plasma methylphenidate. J. Chromatogr. 528: 214-220 (1990).
23. R. Miberg, K.L. Rinehart, Jr., R.L. Sprague, and E.K. Sleator. A reproducible gas chromatographic mass spectrometric assay for low-levels of methylphenidate and ritalinic acid in blood and urine. Biomed. Mass Spectrom. 2: 2-8 (1975)
24. Y.M. Chan, S.J. Soldin, J.M. Swanson, C.M. Deber, J.J. Thiessen, and S. Macleod. Gas chromatographic/mass spectrometric analysis of methylphenidate (ritalin) in serum. Clin. Biochem. 13: 266-272 (1980).
25. T. Aoyama, H. Kotaki, Y. Honda, and F. Nakagawa. Kinetic analysis of enantiomers of threo-metnylphenidate and its metabilite in two healthy subjects after oral administration as determined by a gas chromatographic-mass spectrometric method. J. Pharm. Sci. 79: 465-469 (1990),
26. L.M. Jonkman, M.N. Verbaten, D. de Boer, R.A.A. Maes, J.K. Buitelaar, C. Kemner, J. van Engeland, and J.S. Koelega. Differences in plasma concentrations of the d- and l-threo methylphenidate enantiomers in responding and non-responding children with attention-deficit hyperactivity disorder. Psychiatry Res. 78: 115-118 (1998).
27. B.L. Hungund, J.M. Perel, M.J. Hurwic, J. Sverd, and B.C. Winsberg. Pharmacokinetics of methylphenidate in hyperkinetic children. Br. J. Clin. Pharmacol. 8: 571-576 (1979).
28. V.P. Shah, K.K. Midha, S. Dighe, I.J. McGilveray, J.P. Skelly, A. Yacobi, T. Layloff, C.T. Viswanathan, C.E. Cook, T.D. McDowall, K.A. Pittman, and S. Spertor. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. J. Pharm. Sci. 81:309-312 (1992).
29. W. Wargin, K. Patrick, C. Kilts, C.T. Gaultieri, K. Ellington, R.A. Mueller, G. Kraemer, and G.R. Breese. Pharmacokinetics of methylphenidate in man, rat and monkey J. Pharmacol. Exp. Ther. 226:382-386(1983).
30. N.R. Srinivas, J.W. Hubbard, G. McKay, E.M. Hawes, and K.K. Midha. In vitro hydrolysis of RR,SS-threo-ethylphenidate by blood esterases-differential and enantioselective interspecies variability. Chirality 3:99-103 (1991).